|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-12-16
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Many angiotensin receptor blocker (ARB) monotherapy patients need at least two agents to control blood pressure (BP). We investigated whether initiating intensive treatment with combination amlodipine/valsartan was superior to moderate treatment with amlodipine/valsartan in patients previously uncontrolled on ARB monotherapy.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1473-5598
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
161-70
|
|
pubmed:meshHeading |
pubmed-meshheading:21045734-Amlodipine,
pubmed-meshheading:21045734-Angiotensin Receptor Antagonists,
pubmed-meshheading:21045734-Double-Blind Method,
pubmed-meshheading:21045734-Drug Therapy, Combination,
pubmed-meshheading:21045734-Female,
pubmed-meshheading:21045734-Humans,
pubmed-meshheading:21045734-Hypertension,
pubmed-meshheading:21045734-Male,
pubmed-meshheading:21045734-Tetrazoles,
pubmed-meshheading:21045734-Valine
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy.
|
|
pubmed:affiliation |
Department of Medicine –Cardiovascular, University of Alabama at Birmingham, Birmingham, Alabama 35294-1150, USA. suzanne.oparil@ccc.uab.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Research Support, N.I.H., Extramural
|
